 |
|
Bariatric surgery may resolve liver disease
December 01, 2008Obesity is a growing epidemic in the U.S. with a significant increase in prevalence from 15 percent to 32.9 percent from 1980 to 2004. Nonalcoholic fatty liver disease (NAFLD) is an emerging problem related to the obesity epidemic, becoming one of the most common causes of liver disease in the nation.
Bariatric surgery has become a popular and effective method for rapid and permanent significant weight loss in morbidly obese individuals. A recent study reports bariatric surgery results in improvement of histopathological features of NAFLD. Complications of NAFLD, including steatosis, steatohepatitis and fibrosis appeared to improve or completely resolve in a majority of patients after bariatric surgery-induced weight loss, according to results of a study published in Clinical Gastroenterology and Hepatology, an official journal of the American Gastroenterological Association (AGA) Institute.
"Even today, the effect of weight loss after bariatric surgery on the liver, particularly NAFLD, remains unclear. There is a lack of well-defined trials exploring this relationship," said Gagan K. Sood, MD, of the University of Texas Medical Branch and lead author of the study. "Our team assessed and quantified this effect and found encouraging news: a majority of patients experience complete resolution of NAFLD after bariatric surgery, and the risk of progression of inflammatory changes and fibrosis seems to be minimal."
For this meta-analysis, 15 studies were selected for final data extraction. The mean age of the participants at the time of weight loss surgery ranged from 35.6 to 49 years. Mean BMI at the time of weight loss surgery ranged from 43.9 to 56 kg/m2 and the mean BMI at follow-up liver biopsies ranged from 28.6 to 39kg/m2. Percentage reduction in mean BMI values ranged from 19.11 to 41.76.
The pooled proportion of patients with improvement or resolution in steatosis was 91.6 percent, steatohepatitis was 81.3 percent, fibrosis was 65.5 percent and complete resolution of NASH was 69.5 percent.
Generalizability of these results may require confirmation from multi-center, large scale, well designed trials. Future studies need to be done using uniform histopathological criteria for liver biopsy specimens.
NAFLD encompasses a range of conditions involving the liver that affect people who drink little or no alcohol. The spectrum of NAFLD ranges from hepatic steatosis (fat accumulation in the liver cells) to the more severe non-alcoholic steatohepatitis (NASH) and fibrosis that can progress to cirrhosis, end-stage liver disease, and hepatocellular carcinoma. Prevalence of NAFLD is estimated to be around 70 percent in obese individuals and 85 percent to 95 percent in patients with morbid obesity. The prevalence of NASH is as high as 18.5 percent in obese individuals and 33 percent in those who are morbidly obese. The pathophysiologic mechanisms of NAFLD have not been clearly elucidated as yet, but obesity and insulin resistance are considered to be the main causative factors.
American Gastroenterological Association
For this meta-analysis, 15 studies were selected for final data extraction. The mean age of the participants at the time of weight loss surgery ranged from 35.6 to 49 years. Mean BMI at the time of weight loss surgery ranged from 43.9 to 56 kg/m2 and the mean BMI at follow-up liver biopsies ranged from 28.6 to 39kg/m2. Percentage reduction in mean BMI values ranged from 19.11 to 41.76.
The pooled proportion of patients with improvement or resolution in steatosis was 91.6 percent, steatohepatitis was 81.3 percent, fibrosis was 65.5 percent and complete resolution of NASH was 69.5 percent.
Generalizability of these results may require confirmation from multi-center, large scale, well designed trials. Future studies need to be done using uniform histopathological criteria for liver biopsy specimens.
NAFLD encompasses a range of conditions involving the liver that affect people who drink little or no alcohol. The spectrum of NAFLD ranges from hepatic steatosis (fat accumulation in the liver cells) to the more severe non-alcoholic steatohepatitis (NASH) and fibrosis that can progress to cirrhosis, end-stage liver disease, and hepatocellular carcinoma. Prevalence of NAFLD is estimated to be around 70 percent in obese individuals and 85 percent to 95 percent in patients with morbid obesity. The prevalence of NASH is as high as 18.5 percent in obese individuals and 33 percent in those who are morbidly obese. The pathophysiologic mechanisms of NAFLD have not been clearly elucidated as yet, but obesity and insulin resistance are considered to be the main causative factors.
American Gastroenterological Association
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Defibrillator Meningitis Colon Cancer Cosmic Radiation Hygiene Physical Activity Reproduction Air Pollution Quantum Cerebral Palsy Cholera Triglycerides Ibuprofen Omega-3 Fatty Acids Neurodegenerative Disease Wildlife Conservation Ecosystems Dengue Salmonella Methylmercury Gravitational Wave Sea Urchin Cardiac Arrest Iron Deficiency Glaucoma
See More: Science News Tags
Liver Disease Current Events and Liver Disease News RSSGenetically engineered mice yield clues to 'knocking out' cancer
Deleting two genes in mice responsible for repairing DNA strands damaged by oxidation leads to several types of tumors, providing additional evidence that such stress contributes to the development of cancer.
Young offenders' health critical to rehabilitation
The physical and mental health needs of juvenile offenders should be treated as a priority if offenders held in detention have any real hope of rehabilitation, according to new research from the University of Adelaide, Australia.
Good news for some hard-to-treat hepatitis C patients
In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment.
What is the role of reactive oxygen species in ethanol-mediated cell death of polarized hepatic cells?
Liver disease that results as a consequence of alcohol abuse is a major medical problem worldwide. Ethanol consumption leads to a variety of liver alterations including the accumulation of fat, inflammation of the liver, as well as the presence of scar tissue.
NEJM Study Points to New Era in Hepatitis C Treatment
For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.
Scientists explain how 'death receptors' designed to kill our cells may make them stronger
It turns out that from the perspective of cell biology, Nietzsche may have been right after all: that which does not kill us does make us stronger.
Liver disease 'shrunk' by blood-pressure drug
A blood-pressure medicine has been shown to reverse the effects of early-stage liver failure in some patients.
Environmental pollution increases the risk of liver disease
A new study is the first to show that there is a previously unrecognized role for environmental pollution in liver disease in the general U.S. adult population.
p90RSK: A new therapeutic target for liver fibrosis?
Cirrhosis is a world wide, bad prognosis liver disease and characterized by excessive collagen deposition and liver function damage.
Hyperferritinemia is another surrogate marker of advanced liver disease
High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients.
More Liver Disease Current Events and Liver Disease News Articles
 |
The Liver Book: A Comprehensive Guide to Diagnosis, Treatment, and Recovery by Sanjiv Chopra (Author) It is the portal to total body wellness, the great purifier, and the only human organ that can regenerate itself. But what you don't know about the liver can hurt you! Now, in this complete and authoritative guide that anyone can use and understand, Dr. Sanjiv Chopra explains: The what, where, how, and why of the liver and its miraculous functions |
 |
Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease by Melissa Palmer (Author) In the United States alone, more than four million people are infected with the hepatitis C virus, and chronic liver disease is the twelfth leading cause of death. In this revised and updated edition of her groundbreaking 2000 book, renowned hepatologist Dr. Melissa Palmer discusses all facets of liver disease, from symptoms and tests to treatment options and lifestyle changes. In addition, this comprehensive handbook reveals cutting-edge research on the dangers of hepatitis C, one of the world's fasting-growing microbial threats. |
 |
The Liver Book by Atria Books This book tells you all that you ever wanted to know about the liver, its functions and all the diseases and disorders connected with it. Liver disease afflicts millions of people worldwide, ranging from a mild, reversible illness to advanced disease with the potential for myriad and even life-threatening complications. Dr. Sanjiv Chopra's Liver Book acts like a comprehensive guide to the diagnosis, treatment and recovery from liver diseases. |
 |
Holistic Approach to Liver Diseases by Jean Grandoit (Author) |
 |
FlameEz-Liver, 60 Capsules/Bottle by FlameEz There are many types of liver disease. Whether the liver is infected with a virus or injured by chemicals, the process of the liver damage always involves inflammation. If properly treated, the inflammation may go away and the liver can heal itself. If left untreated, the inflamed liver will start to scar. As excess scar tissue grows, it replaces healthy liver tissue and leads to fibrosis or cirrhosis. Although it is important to treat the liver disease in the inflammation and fibrosis stages, the treatment choice is limited because many drugs are metabolized by the liver and a few drugs that are used routinely to treat liver disease have significant side effects. Natural remedies are available as alternative approach for liver disease. FlameEz-Liver is a high quality natural liver... |
 |
Livers & Heart Disease by Absolutely Kosher |
 |
The Liver Disorders and Hepatitis Sourcebook (Sourcebooks) by Howard Worman (Author) The latest information on living with and treating liver disorders The Liver Disorders and Hepatitis Sourcebook, Revised Edition, gives you frank assessments of the latest therapies and drugs. It also provides advice on how you can navigate the day-to-day challenges of living with a liver disorder, and diet and nutrition guidelines, including the truth about the effectiveness of herbal remedies and liver-cleansing diets. |
 |
PetAlive Immunity and Liver Support for Protection Against Disease (60 Caps) by PetAlive PetAlive Immunity and Liver Support capsules contain a combination of especially selected herbs known for their ability to cleanse and purify the system, improve immune functioning and support liver health. Used as a general tonic or to protect against disease, Immunity and Liver Support capsules are also very effective during convalescence and can help your pet in the recovery phase after illness. Use PetAlive Immunity and Liver Support to boost immune functioning and resistance against disease and infection, including viral and bacterial infection; improve liver health and functioning and aid in the elimination of systemic toxins; act as a tonic for the lymphatic system; help to counter the harmful effects of frequent vaccinations and antibiotic treatment; promote and speed up healing... |
 |
Zakim and Boyer's Hepatology: A Textbook of Liver Disease, 2-Volume Set (Hepatology (Zakim)) by Thomas D. Boyer MD (Author), Theresa L. Wright MD (Author), Michael P. Manns MD (Author) Long considered the defining work in Hepatology, this trusted 2-volume masterwork has been refocused to zero in on just the clinical knowledge you need to provide today’s best patient care. The most comprehensive text on the subject, this book is still thoroughly grounded in basic science—but now that science is focused on the most clinically relevant developments. Find definitive coverage of all aspects of liver disease in a new full-color format that keeps pace with your evolving practice.* Covers all liver diseases currently seen in clinical practice—in two clinically focused volumes. * Replaces previous editions’ basic science section with the new, more concise "Pathophysiology of Therapeutic Targets" section. * Highlights key references, all current and up to date, to help... |
 |
Drug-Induced Liver Disease by Taylor & Francis Featuring more than 4100 references, Drug-Induced Liver Disease will be an invaluable reference for gastroenterologists, hepatologists, family physicians, internists, pathologists, pharmacists, pharmacologists, and clinical toxicologists, and graduate and medical school students in these disciplines. |
| © 2009 BrightSurf.com |